Finger-Prick Autologous Blood in the Treatment of Persistent Corneal Epithelial Defects
Conclusions:
FAB in combination with conventional treatment may be successfully used in the management of refractory PEDs. No adverse effects arising from FAB treatment were observed.
Source: Cornea - Category: Opthalmology Tags: Clinical Science Source Type: research
More News: Brain | Corneal Transplant | Diabetes | Diabetic Ulcers | Endocrinology | Eyes | Neurology | Neuroscience | Opthalmology | Science | Study